+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation



Assessment of oral candidiasis in patients with respiratory disease and efficacy of a new nystatin formulation



British Medical Journal 292(6537): 1699-1700



Fifty consecutive patients with respiratory diseases who developed oropharyngeal candidiasis were assessed clinically and microbiologically before and after seven days' treatment with nystatin suspension or pastilles (a new formulation). In 45 patients in whom microbiology yielded positive results there was frequent associated use of oral corticosteroids, antibiotics, sedatives, and inhaled corticosteroid, while in a few patients atropine analogues may have predisposed to infection. Dentures were worn by 32 of the infected patients. Concomitant treatment of dentures in chronically infected patients appeared to improve the therapeutic response. Pastilles and suspension were equally efficacious both clinically and microbiologically. The potential for enhanced drug delivery to the oropharynx suggests that nystatin pastilles may be useful in patients in whom poor compliance seems likely.

(PDF emailed within 0-6 h: $19.90)

Accession: 001533118

Download citation: RISBibTeXText

PMID: 3089361

DOI: 10.1136/bmj.292.6537.1699



Related references

Efficacy of a new nystatin formulation in oral candidiasis. British Medical Journal 293(6546): 563-564, 1986

Oral sustained release nystatin tablets for the treatment of oral candidiasis: formulation development and validation of UV spectrophotometric analytical methodology for content determination. Drug Development and Industrial Pharmacy 36(5): 594-600, 2011

Assessment of the usefulness of nystatin in suspension in the treatment of oral candidiasis. Czasopismo Stomatologiczne 24(5): 477-480, 1971

Efficacy of nystatin for the treatment of oral candidiasis: a systematic review and meta-analysis. Drug Design, Development and Therapy 10(): 1161-1171, 2016

An assessment of the clinical efficacy of a novel oral formulation of tilmicosin in the treatment of induced respiratory pasteurellosis in young calves. Journal of Veterinary Pharmacology & Therapeutics 20(SUPPL 1): 132-133, 1997

Nystatin lozenges a useful treatment for oral candidiasis in cancer patients. Current Therapeutic Research 42(6): 1201-1209, 1987

Ketoconazole suspension vs nystatin in cancer patients with oral candidiasis. 1984

Comparison of clotrimazole with nystatin in preventing oral candidiasis in neutropenic patients. Indian Journal of Medical Research 88(NOV): 416-420, 1988

Oral treatment of oropharyngeal candidiasis with nystatin versus ketoconazole in cancer patients a randomized study. Drug Investigation 2(2): 71-75, 1990

Oropharyngeal candidiasis in patients with AIDS: randomized comparison of fluconazole versus nystatin oral suspensions. Clinical Infectious Diseases 24(6): 1204-1207, 1997

Activity of an Intralipid formulation of nystatin in murine systemic candidiasis. International Journal of Antimicrobial Agents 38(4): 336-340, 2012

Comparative trial of oral clotrimazole and nystatin for oropharyngeal candidiasis prophylaxis in orthotopic liver transplant patients. Oral Surgery Oral Medicine Oral Pathology 74(5): 567-571, 1992

In vitro antifungal susceptibility of Candida isolates from HIV-infected patients with oral candidiasis treated with fluconazole and/or nystatin. Abstracts of the Interscience Conference on Antimicrobial Agents & Chemotherapy 34(0): 212, 1994

Innovative formulation of nystatin particulate systems in toothpaste for candidiasis treatment. Pharmaceutical Development and Technology 21(3): 282-287, 2015